CD200Fc, which links the extracellular domain of CD200 with the murine IgG2a Fc region, effectively inhibits resistance to tumor growth in CD80-transfected EL4 or C1498 leukemia tumor cell allograft mice. Here, CD200 is linked to leukemia.